Shares of Aurora Cannabis Inc. ACB shed 1.40% to $6.33 Wednesday, on what proved to be an all-around mixed trading session ...
Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.
Julian Lin updates his views on cannabis REITs IIPR and NewLake Capital and shares his changed thesis on MSOs.
Although Elon Musk attracts most of the headlines, the US Cabinet is full of other wealthy individuals who have significant ...
On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk. Check out why I rate the fund a buy.
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside ...
Aurora says net revenue for the three months ended Dec. 31, 2024 topped $88.1 million, up 37 per cent year-over-year. The ...
Tilray, Aurora Cannabis, Canopy Growth, Turning Point Brands, and Innovative Industrial Properties are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis ...
Aurora Cannabis, Canopy Growth, Tilray, Gibraltar Industries, and Turning Point Brands are the five Cannabis stocks to watch ...
Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results